Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
Journal of Pharmaceutical and Biomedical Analysis
|
September 23, 2022
Development and validation of a bioanalytical method for the quantification of axitinib from plasma and capillary blood using volumetric absorptive microsampling (VAMS) and on-line solid phase extraction (SPE) LC-MS
Patrick Opitz, Sebastian Zimmermann, Anna M Mc Laughlin, et al.
Anticancer Research
|
July 24, 2010
A phase IA, open-label, dose-escalating study of PTK787/ZK 222584 administered orally on a continuous dosing schedule in patients with advanced cancer
Joachim Drevs, Michael Medinger, Klaus Mross, et al.
Journal of Cancer
|
April 4, 2017
Efficacy of Cabazitaxel Treatment in Metastatic Castration Resistant Prostate Cancer in Second and Later Lines. An Experience from Two German Centers
Stefanie Zschäbitz, Sonia Vallet, Boris Hadaschik, et al.
Oncology Research and Treatment
|
December 23, 2014
Quality of life under capecitabine (Xeloda®) in patients with metastatic breast cancer: data from a german non-interventional surveillance study
Volkmar Müller, Stefan Fuxius, Claus-Christoph Steffens, et al.
In Vivo (Athens, Greece)
|
January 2, 2023
Usage of Complementary and Alternative Methods, Lifestyle, and Psychological Variables in Cancer Care
Catalina Hoppe, Jens Buntzel, Ludwig Fischer VON Weikersthal, et al.
Journal of Cancer Research and Clinical Oncology
|
April 25, 2012
A prospective multicenter study of treosulfan in elderly patients with recurrent ovarian cancer: results of a planned safety analysis
Sven Mahner, Gülten Oskay-Özcelik, Elke Heidrich-Lorsbach, et al.
Cancer Research
|
July 19, 2002
PTK787/ZK 222584, a specific vascular endothelial growth factor-receptor tyrosine kinase inhibitor, affects the anatomy of the tumor vascular bed and the functional vascular properties as detected by dynamic enhanced magnetic resonance imaging
Joachim Drevs, Ralph Müller-Driver, Christine Wittig, et al.
Oncology Research and Treatment
|
February 7, 2024
Spirituality in Oncology: Relations between Spirituality, Its Facets, and Psychological and Demographic Factors in Cancer Patients in Germany
Gina Heuschkel, Ludwig Fischer von Weikersthal, Constanze Junghans, et al.
Anticancer Research
|
October 3, 2022
Retrospective Analysis of Treatment Pathways in Patients With BRAF<sup>V600E</sup>-mutant Metastatic Colorectal Carcinoma - MORSE<sup>CRC</sup>
Armin Gerger, Wolfgang Eisterer, Stefan Fuxius, et al.
Gynecologic Oncology Research and Practice
|
March 14, 2017
Preference of elderly patients' to oral or intravenous chemotherapy in heavily pre-treated recurrent ovarian cancer: final results of a prospective multicenter trial
Radoslav Chekerov, Philipp Harter, Stefan Fuxius, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
Journal of Pharmaceutical and Biomedical Analysis
|
September 23, 2022
Development and validation of a bioanalytical method for the quantification of axitinib from plasma and capillary blood using volumetric absorptive microsampling (VAMS) and on-line solid phase extraction (SPE) LC-MS
Patrick Opitz, Sebastian Zimmermann, Anna M Mc Laughlin, et al.
Anticancer Research
|
July 24, 2010
A phase IA, open-label, dose-escalating study of PTK787/ZK 222584 administered orally on a continuous dosing schedule in patients with advanced cancer
Joachim Drevs, Michael Medinger, Klaus Mross, et al.
Journal of Cancer
|
April 4, 2017
Efficacy of Cabazitaxel Treatment in Metastatic Castration Resistant Prostate Cancer in Second and Later Lines. An Experience from Two German Centers
Stefanie Zschäbitz, Sonia Vallet, Boris Hadaschik, et al.
Oncology Research and Treatment
|
December 23, 2014
Quality of life under capecitabine (Xeloda®) in patients with metastatic breast cancer: data from a german non-interventional surveillance study
Volkmar Müller, Stefan Fuxius, Claus-Christoph Steffens, et al.
In Vivo (Athens, Greece)
|
January 2, 2023
Usage of Complementary and Alternative Methods, Lifestyle, and Psychological Variables in Cancer Care
Catalina Hoppe, Jens Buntzel, Ludwig Fischer VON Weikersthal, et al.
Journal of Cancer Research and Clinical Oncology
|
April 25, 2012
A prospective multicenter study of treosulfan in elderly patients with recurrent ovarian cancer: results of a planned safety analysis
Sven Mahner, Gülten Oskay-Özcelik, Elke Heidrich-Lorsbach, et al.
Cancer Research
|
July 19, 2002
PTK787/ZK 222584, a specific vascular endothelial growth factor-receptor tyrosine kinase inhibitor, affects the anatomy of the tumor vascular bed and the functional vascular properties as detected by dynamic enhanced magnetic resonance imaging
Joachim Drevs, Ralph Müller-Driver, Christine Wittig, et al.
Oncology Research and Treatment
|
February 7, 2024
Spirituality in Oncology: Relations between Spirituality, Its Facets, and Psychological and Demographic Factors in Cancer Patients in Germany
Gina Heuschkel, Ludwig Fischer von Weikersthal, Constanze Junghans, et al.
Anticancer Research
|
October 3, 2022
Retrospective Analysis of Treatment Pathways in Patients With BRAF<sup>V600E</sup>-mutant Metastatic Colorectal Carcinoma - MORSE<sup>CRC</sup>
Armin Gerger, Wolfgang Eisterer, Stefan Fuxius, et al.
Gynecologic Oncology Research and Practice
|
March 14, 2017
Preference of elderly patients' to oral or intravenous chemotherapy in heavily pre-treated recurrent ovarian cancer: final results of a prospective multicenter trial
Radoslav Chekerov, Philipp Harter, Stefan Fuxius, et al.
Page
of 3